Contemporary Considerations for Constructing a Genetic Risk Score: An Empirical Approach

Genetic Epidemiology

Volumn 39, Issue 6, 2015, Pages 439-445

  Goldstein, Benjamin A ^a   Yang, Lingyao ^b   Salfati, Elias ^b   Assimes, Themistoclies L ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary heart disease; Risk assessment; Risk score

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC RISK SCORE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; RISK FACTOR;

COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84939466828     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21912     Document Type: Article

References (37)

1. Amin, N, van Duijn CM, Janssens ACJW. 2009. Genetic scoring analysis: a way forward in genome wide association studies? Eur J Epidemiol 24:585-587.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300.
3. Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park J-H. 2013. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat. Genet. 45:400-405, 405e1-405e3.
4. Cook NR. 2007. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928-935.
5. Crowson CS, Atkinson EJ, Therneau TM. 2014. Assessing calibration of prognostic risk scores. Stat Methods Med Res.
6. Demler OV, Pencina MJ, D'Agostino RB. 2012. Misuse of DeLong test to compare AUCs for nested models. Stat Med 31:2577-2587.
7. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Simon KC, Aubin C, Bauer D, Heubach JF, Sandbrink R and others. 2009. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 8:1111-1119.
8. Goldstein BA, Hubbard AE, Cutler A, Barcellos LF. 2010. An application of random forests to a genome-wide association dataset: methodological considerations & new findings. BMC Genetics 11:49.
9. Goldstein BA, Knowles JW, Salfati E, Ioannidis JPA, Assimes TL. 2014. Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example. Front Genet 5:254.
10. Hemani G, Shakhbazov K, Westra H-J, Esko T, Henders AK, McRae AF, Yang J, Gibson G, Martin NG, Metspalu A and others. 2014. Detection and replication of epistasis influencing transcription in humans. Nature 508:249-253.
11. Hill WG, Goddard ME, Visscher PM. 2008. Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet 4:e1000008.
12. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. 2012. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44:955-959.
13. Jostins L, Barrett JC. 2011. Genetic risk prediction in complex disease. Hum Mol Genet 20:R182-R188.
14. Kannry JL, Williams MS. 2013. Integration of genomics into the electronic health record: mapping terra incognita. Genet Med 15:757-760.
15. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. 2010. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34:816-834.
16. Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R, Hao L, Kiang A, Paschall J, Phan L and others. 2007. The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 39:1181-1186.
17. Obuchowski NA & Lieber ML. 1998. Confidence intervals for the receiver operating characteristic area in studies with small samples. Acad Radiol 5:561-571.
18. Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JAC. 2012. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 21:223-242.
19. Pepe MS, Kerr KF, Longton G, Wang Z. 2013. Testing for improvement in prediction model performance. Stat Med 32:1467-1482.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ and others. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
21. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752.
22. R Core Team. 2012. R: A language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
23. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AFR, Barbalic M, Gieger C and others. 2011. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43:333-338.
24. Simonson MA, Wills AG, Keller MC, McQueen MB. 2011. Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease risk. BMC Med Genet 12:146.
25. Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, Voight BF, Kraft P, Chen R, Kallberg HJ, Kurreeman FAS and others. 2012. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 44:483-489.
26. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P. 1999. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 282:2012-2018.
27. Thanassoulis G, Vasan RS. 2010. Genetic cardiovascular risk prediction: will we get there? Circulation 122:2323-2334.
28. Thanassoulis G, Peloso GM, Pencina MJ, Hoffmann U, Fox CS, Cupples LA, Levy D, D'Agostino RB, Hwang S-J, O'Donnell CJ. 2012. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet 5:113-121.
29. Visscher PM, Brown MA, McCarthy MI, Yang J. 2012. Five years of GWAS discovery. Am J Hum Genet 90:7-24.
30. Weijmans M, de Bakker PIW, van der Graaf Y, Asselbergs FW, Algra A, Jan de Borst G, Spiering W, Visseren FLJ, SMART Study Group. 2015. Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease. Atherosclerosis 239:451-458.
31. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff L and others. 2014. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42:D1001-D1006.
32. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA. 1996. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 49:223-233.
33. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847.
34. Wray NR, Purcell SM, Visscher PM. 2011. Synthetic associations created by rare variants do not explain most GWAS results. PLoS Biol 9:e1000579.
35. Wu J, Pfeiffer RM, Gail MH. 2013. Strategies for developing prediction models from genome-wide association studies. Genet Epidemiol 37:768-777.
36. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J and others. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937-952.
37. The ARIC investigators. 1989. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129:687-702.